JP Patent

JP7423800B2 — ネコにおける心臓疾患の予防および／または治療のためのｓｇｌｔ－２阻害剤の使用

Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2024-01-29 · 2y expired

What this patent protects

Patent listed against Brenzavvy.

Drugs covered by this patent

Brenzavvy (BEXAGLIFLOZIN) · Theracosbio

Patent Metadata

Patent number: JP7423800B2
Jurisdiction: JP
Classification: —
Expires: 2024-01-29
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Vetmedica GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.